首页> 外国专利> The pharmacological components include pertusumab, which is a thyroid hormone based enzyme receptor

The pharmacological components include pertusumab, which is a thyroid hormone based enzyme receptor

机译:药理成分包括pertusumab,这是一种基于甲状腺激素的酶受体

摘要

It refers to a kind of drug synthesis, including (a) a single human clonal antibody which is re synthesized, such as pertuzumab, whose chemical characteristics are divided into 3 and 4, its light variable and heavy variable amino acid sequences; and (b) a therapeutic agent, such as a chemical therapist, an anti hormonal compound, A citoquina, etc. The antibody is an inhibitor of the thyroid receptor, the thyroid hormone quinassa. This ingredient can prolong the condition or survival time of a cancer patient at least 20% longer than other drugs, and is an effective method for treating ovarian cancer and peritoneal cancer,Tubal cancer, metabolic breast cancer
机译:它是一种药物合成方法,包括:(a)一种被合成的人克隆抗体,如pertuzumab,其化学特性分为3和4,其轻可变氨基酸序列和重可变氨基酸序列。 (b)一种治疗剂,例如化学治疗师,抗激素化合物,Citoquina等。该抗体是甲状腺受体,甲状腺激素quinassa的抑制剂。与其他药物相比,该成分可以延长癌症患者的病情或存活时间至少20%,是治疗卵巢癌和腹膜癌,输卵管癌,代谢性乳腺癌的有效方法

著录项

  • 公开/公告号PE20061302A1

    专利类型

  • 公开/公告日2006-12-23

    原文格式PDF

  • 申请/专利权人 GENENTECH INC.;

    申请/专利号PE20180200600

  • 发明设计人 DERYNCK MIKA K.;KELSEY STEPHEN M.;

    申请日2006-02-23

  • 分类号A61K39/395;A61P35;

  • 国家 PE

  • 入库时间 2022-08-21 20:56:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号